Céline Cano
Impact in
- Toxicology top 2%
- Oncology top 10%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
Papers in
- Toxicology 11
- Bioactive Compounds and Antitumor Agents 9
-
- Synthesis and Biological Evaluation 6
- Click Chemistry and Applications 4
- Co-authors
- Roger J. Griffin (28 shared papers)Ian R. Hardcastle (25 shared papers)Bernard T. Golding (28 shared papers)David R. Newell (16 shared papers)Nicola J. Curtin (10 shared papers)Suzannah J. Harnor (12 shared papers)Martin E. M. Noble (8 shared papers)Simon L. Hill (2 shared papers)
- Journals
- Organic & Biomolecular Chemistry (8 papers)Journal of Medicinal Chemistry (8 papers)Oncotarget (4 papers)Clinical Chemistry (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)
- Partner nations
- United KingdomUnited StatesJapan
In The Last Decade
Céline Cano
57 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 88
- Toxicology 118
- Oncology 398
- Organic Chemistry 387
- Molecular Biology 872
- Cancer Research 92
Countries citing papers authored by Céline Cano
This map shows the geographic impact of Céline Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Cano more than expected).
Fields of papers citing papers by Céline Cano
This network shows the impact of papers produced by Céline Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Cano. The network helps show where Céline Cano may publish in the future.
Co-authors
The 25 scholars most cited alongside Céline Cano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 113 | |
| 2 | 2015 | 103 | |
| 3 | 2019 | 83 | |
| 4 | 2008 | 78 | |
| 5 | 2007 | 73 | |
| 6 | 2019 | 66 | |
| 7 | 2017 | 63 | |
| 8 | 2011 | 56 | |
| 9 | 2013 | 47 | |
| 10 | 2018 | 46 | |
| 11 | 2016 | 46 | |
| 12 | 2010 | 40 | |
| 13 | 2023 | 39 | |
| 14 | 2016 | 33 | |
| 15 | 2014 | 32 | |
| 16 | 2017 | 27 | |
| 17 | 2010 | 24 | |
| 18 | 2022 | 23 | |
| 19 | 2012 | 23 | |
| 20 | 2007 | 22 |
About Céline Cano
Céline Cano is a scholar working on Toxicology, Organic Chemistry, Oncology, Molecular Biology and Pharmaceutical Science, having authored 59 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (10 papers), Bioactive Compounds and Antitumor Agents (9 papers), Cancer-related Molecular Pathways (8 papers), DNA Repair Mechanisms (8 papers), Protein Degradation and Inhibitors (6 papers), Synthesis and Biological Evaluation (6 papers), Biochemical and Molecular Research (4 papers) and Click Chemistry and Applications (4 papers). The work is most often cited by research in Toxicology (118 citations), Oncology (398 citations), Organic Chemistry (387 citations), Molecular Biology (872 citations) and Cancer Research (92 citations). Céline Cano has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Roger J. Griffin, Ian R. Hardcastle, Bernard T. Golding, David R. Newell, Nicola J. Curtin, Suzannah J. Harnor, Martin E. M. Noble, Simon L. Hill, Simon H. L. Thomas and Caroline J. Richardson. Their work appears in journals such as Organic & Biomolecular Chemistry, Journal of Medicinal Chemistry, Oncotarget, Clinical Chemistry and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.